Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis

Key Points

Key points are not available for this paper at this time.

Abstract

Human immunodeficiency virus type 1 drug resistance among ART-experienced patients in Switzerland is a well-controlled relic from the era before combination ART. Emergence of drug resistance can be virtually stopped with new potent therapies and close monitoring.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Scherrer et al. (Tue,) studied this question.

synapsesocial.com/papers/69d93c7bed2e131d3c68407d https://doi.org/https://doi.org/10.1093/cid/ciw128

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy1989 · 1,559 citations
2Declining Prevalence of HIV-1 Drug Resistance in Treatment-Failing Patients: A Clinical Cohort Study2007 · 32 citations
3Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy1997 · 1,909 citations
4Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 20122015 · 66 citations
5Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study2010 · 14 citations

Bookmark

View Full Paper